CKAP2 (cytoskeleton associated protein 2) is a new prognostic marker in HER2-negative luminal breast cancer

被引：0
|
作者：
Sim, S. H.
Bae, C-D
Kwon, Y.
Park, I. H.
Lee, K. S.
Jung, S-Y
Lee, S.
Kang, H-S
Lee, E. S.
Kim, H-S
Hong, K-M
Ro, J.
机构：
[1] Natl Canc Ctr, Ctr Breast Canc, Goyang, South Korea
[2] Natl Canc Ctr, Res Inst, Goyang, South Korea
[3] Sungkyunkwan Univ, Sch Med, Suwon, South Korea
[4] Inje Univ, Ilsan Paik Hosp, Goyang, South Korea
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.SABCS15-P5-08-25
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P5-08-25
引用
下载
收藏
页数：1
相关论文
共 50 条
  • [31] New HER2-negative breast cancer subtype responsive to anti-HER2 therapy identified
    Ian A. MacNeil
    David J. Burns
    Benjamin E. Rich
    Sajjad M. Soltani
    Samantha Kharbush
    Nicole G. Osterhaus
    Brian F. Sullivan
    Douglas M. Hawkins
    Jodie R. Pietruska
    Lance G. Laing
    Journal of Cancer Research and Clinical Oncology, 2020, 146 : 605 - 619
  • [32] New HER2-negative breast cancer subtype responsive to anti-HER2 therapy identified
    MacNeil, Ian A.
    Burns, David J.
    Rich, Benjamin E.
    Soltani, Sajjad M.
    Kharbush, Samantha
    Osterhaus, Nicole G.
    Sullivan, Brian F.
    Hawkins, Douglas M.
    Pietruska, Jodie R.
    Laing, Lance G.
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2020, 146 (03) : 605 - 619
  • [33] Transient phosphorylation of tumor associated microtubule associated protein (TMAP)/cytoskeleton associated protein 2 (CKAP2) at Thr-596 during early phases of mitosis
    Hong, Kyung Uk
    Choi, Yong-Bock
    Lee, Jung-Hwa
    Kim, Hyun-Jun
    Kwon, Hye-Rim
    Seong, Yeon-Sun
    Kim, Heung Tae
    Park, Joobae
    Bae, Chang-Dae
    Hong, Kyeong-Man
    EXPERIMENTAL AND MOLECULAR MEDICINE, 2008, 40 (04): : 377 - 386
  • [34] KLP-PI: a new prognostic index for luminal B HER-2-negative breast cancer
    Pan, Chuanmeng
    Bhandari, Adheesh
    Liu, Yehuan
    Xia, Erjie
    Lin, Lizhi
    Lv, Shixu
    Wang, Ouchen
    HUMAN CELL, 2019, 32 (02) : 172 - 184
  • [35] Comprehensive Evaluation of Ki67 in Luminal/HER2-Negative Breast Cancer in the AMBER Consortium
    Khoury, Thaer
    Zirpoli, Gary
    Cohen, Stephanie M.
    Merzianu, Mihai
    Troester, Melissa
    Geradts, Joseph
    Worral, Amber
    Bshara, Wiam
    Ambrosone, Christine
    LABORATORY INVESTIGATION, 2016, 96 : 50A - 50A
  • [36] KLP-PI: a new prognostic index for luminal B HER-2-negative breast cancer
    Chuanmeng Pan
    Adheesh Bhandari
    Yehuan Liu
    Erjie Xia
    Lizhi Lin
    Shixu Lv
    Ouchen Wang
    Human Cell, 2019, 32 : 172 - 184
  • [37] Comprehensive Evaluation of Ki67 in Luminal/HER2-Negative Breast Cancer in the AMBER Consortium
    Khoury, Thaer
    Zirpoli, Gary
    Cohen, Stephanie M.
    Merzianu, Mihai
    Troester, Melissa
    Geradts, Joseph
    Worral, Amber
    Bshara, Wiam
    Ambrosone, Christine
    MODERN PATHOLOGY, 2016, 29 : 50A - 50A
  • [38] Review of concepts in therapeutic decision-making in HER2-negative luminal metastatic breast cancer
    Alvarez-Lopez, I
    Bezares, S.
    Portulas, E. Dalmau
    Garcia-Martinez, E.
    Garcia-Saenz, J. A.
    Gil-Gil, M.
    Martinez de Duenas, E.
    Ribelles, N.
    Santaballa Bertran, A.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2020, 22 (08): : 1364 - 1377
  • [39] Review of concepts in therapeutic decision-making in HER2-negative luminal metastatic breast cancer
    I. Alvarez-Lopez
    S. Bezares
    E. Dalmau Portulas
    E. García-Martínez
    J. Á. García-Sáenz
    M. Gil-Gil
    E. Martínez de Dueñas
    N. Ribelles
    A. Santaballa Bertrán
    Clinical and Translational Oncology, 2020, 22 : 1364 - 1377
  • [40] Breast cancer stem cells are associated with HER2-mediated radioresistance and the molecular subtype conversion of HER2-negative breast cancer
    Kim, Jae-Sung
    CANCER RESEARCH, 2018, 78 (13)
12345